Effect of Percutaneous Coronary Intervention on Survival in Patients with Stable Ischemic Heart Disease

Area of Science:

• Cardiology
• Interventional Cardiology
• Clinical Trials

Background:

• Stable ischemic heart disease (SIHD) affects numerous patients worldwide.
• Optimal management strategies for SIHD remain a focus of clinical research.
• Percutaneous coronary intervention (PCI) is a common revascularization procedure.

Purpose of the Study:

• To evaluate the impact of percutaneous coronary intervention (PCI) on survival rates in patients with stable ischemic heart disease (SIHD).
• To review the evidence regarding the efficacy of PCI versus optimal medical therapy for SIHD.

Main Methods:

• The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial is a large randomized trial.
• The ISCHEMIA trial compares initial coronary revascularization (PCI or surgery) with optimal medical therapy alone in SIHD patients.
• Analysis of existing randomized trials assessing PCI for SIHD survival benefits.

Main Results:

• Prior randomized trials have generally shown no survival benefit with PCI in SIHD.
• Cardiac events post-PCI often occur in non-stented segments due to plaque rupture.
• The ISCHEMIA trial is unlikely to demonstrate a survival benefit specifically for PCI, though revascularization may benefit high-risk groups.

Conclusions:

• While PCI can alleviate symptoms in SIHD, it does not appear to prolong survival.
• Optimal medical therapy remains a cornerstone of SIHD management.
• Further research, including the ISCHEMIA trial, will refine understanding of revascularization strategies in SIHD.